Alveolar macrophages (AM) are the predominant effector cell in the lungs and contribute to a critical first line of defense against bacterial pathogens via recognition by pattern recognition receptor (PRR) such TLR4. Recognizing that TLR4 can signal through MyD88-dependent and MyD88-independent pathways, whether HIV impairs one or both TLR4 signaling pathways in human macrophages is not known. Comparing human U937 macrophages with human HIV+ U1 macrophages (HIV-infected U937 subclone), the current study demonstrates that HIV infection is associated with impaired human macrophage TLR4-mediated signaling, specifically targeting the MyD88-dependent TLR4-mediated signaling pathway (reduced MyD88-IRAK interaction, reduced IRAK phosphorylation, reduced NF-kB nuclear translocation, and reduced TNFα release) while preserving the MyD88-independent TL4-mediated signaling pathway (preserved STAT1 phosphorylation, preserved IRF nuclear translocation, and preserved IL-10 and RANTES release). Extracellular TLR4 signaling complex was intact (similar levels of CD14 and MD2), and similar patterns of response were observed in clinically relevant alveolar macrophages from healthy and asymptomatic HIV+
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ABSTRACT:
Alveolar macrophages (AM) are the predominant effector cell in the lungs and contribute to a critical first line of defense against bacterial pathogens via recognition by pattern recognition receptor (PRR) such TLR4. Recognizing that TLR4 can signal through MyD88-dependent and MyD88-independent pathways, whether HIV impairs one or both TLR4 signaling pathways in human macrophages is not known. Comparing human U937 macrophages with human HIV+ U1 macrophages (HIV-infected U937 subclone), the current study demonstrates that HIV infection is associated with impaired human macrophage TLR4-mediated signaling, specifically targeting the MyD88-dependent TLR4-mediated signaling pathway (reduced MyD88-IRAK interaction, reduced IRAK phosphorylation, reduced NF-kB nuclear translocation, and reduced TNFα release) while preserving the MyD88-independent TL4-mediated signaling pathway (preserved STAT1 phosphorylation, preserved IRF nuclear translocation, and preserved IL-10 and RANTES release). Extracellular TLR4 signaling complex was intact (similar levels of CD14 and MD2), and similar patterns of response were observed in clinically relevant alveolar macrophages from healthy and asymptomatic HIV+ persons at high clinical risk for pneumonia. Taken together, these data support the concept that chronic HIV infection is associated with specific and targeted disruption of critical macrophage innate immune TLR4 signaling, which in turn may contribute to susceptibility and disease pathogenesis of bacterial pneumonia.
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INTRODUCTION:
Bacterial pneumonia remain a frequent and serious complication in asymptomatic HIV+ persons, despite relatively preserved peripheral blood CD4+ T-lymphocyte counts 1 , use of HAART with undetectable plasma viral loads 2 . These individuals have up to 25-fold greater risk of bacterial pneumonia compared to their healthy cohorts 3 . However, the mechanism contributing to this increased risk is not well understood. Toll-like receptor 4 (TLR4) represents a critical pattern recognition receptor in the innate immune host cell response to bacterial infection. Functional deficiency or genetic deletion of TLR 4 increases susceptibility to H. Influenza, Streptococcus pneumoniae, and K. pneumoniae respiratory tract infection in murine models 4, 5 . Another indication of its importance is that TLR4 polymorphisms are associated with increased susceptibility to lung infection 6 . Our lab recently reported impaired TLR4-mediated TNFα release in alveolar macrophages from asymptomatic HIV+ persons at increased clinical risk for bacterial pneumonia 7 . Increased susceptibility may be in part related to reduced alveolar macrophage ERK1/2 MAP kinase phosphorylation attributed to elevated MKP-1 activity 7 , and constitutive PI3K activation and heightened PI3K signaling in response to TLR4 activation 8 . These data suggest that the host cell proinflammatory cytokine may be suboptimal in the lungs of HIV+ persons and may in part contribute to increased bacterial pneumonia susceptibility and pathogenesis.
TLR4 is the most studied of the TLR family of innate receptors 9 . It is a unique member of the TLR family of mammalian receptors in that TLR4 is capable of both adaptor molecule MyD88-dependent and MyD88-independent signaling [10] [11] [12] . TLR4-mediated
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MyD88-dependent recognition of bacterial cell wall occurs at the cell surface 11, 13 , does not require receptor internalization 11 , involves IRAK phosphorylation, and activation of TRAF6, NF-kB and MAP kinases (such as ERK1/2, p38 and JNK), with the subsequent release of proinflammatory cytokines such as TNFα 14 that may contribute to an effective host defense response to bacteria. In contrast, TLR4-mediated MyD88-independent signaling requires receptor internalization and is mediated through TRIF . However, whether both MyD88-dependent and MyD88-independent pathways are impaired by HIV infection is not known. Using human macrophage cell lines and clinically relevant human alveolar macrophages, the purpose of this study was to further examine the influence of HIV infection on TLR4-mediated intracellular signaling in greater detail, focusing on MyD88-dependent and MyD88-independent TLR4 signaling pathways.
Materials and Methods:
Study Subjects. Recruited healthy and asymptomatic HIV+ subjects showed no evidence of active pulmonary disease and with normal spirometry. Human alveolar macrophages. Select experiments using human alveolar macrophages were carried out to determine clinical relevance of the study. Recruited healthy and asymptomatic HIV+ individuals were without evidence for active pulmonary disease and had normal spirometry. Healthy individuals were confirmed to be HIV seronegative by ELISA and had no known risk factors for HIV infection. For the HIV+ subjects, peripheral blood CD4 lymphocyte counts were >200 cells/mm , although whether the MyD88-dependent TLR4 signaling pathway is intact was not determined. To further examine the influence of HIV on the MyD88-dependent TLR4 signaling pathway, human U937 macrophages demonstrated a robust release of TNFα in response to TLR4 ligand challenge (lipid A, 10 µg/ml), and macrophage TNFα release was significantly reduced in the presence of anti-TLR4 neutralizing antibody (Fig. 1A, left panel) . Similarly, TNFα release by human HIV+ U1 macrophages was also significantly reduced in the presence of anti-TLR4 neutralizing antibody (Fig. 1A, right panel) , although overall the levels of TNFα release were significantly lower compared to human U937 macrophages, consistent with our previous (Fig. 1B, left panel) . This data suggest that the activity of IRAK in HIV+ macrophages is diminished in response to TLR4 activation and is in agreement with previous report 24 . Recognizing the importance of NF-kB in TLRmediated signaling pathway 25 , human U937 and U1 macrophages were incubated with lipid A (10 μ g/ml) up to 120 minutes, nuclear and cytoplasmic extract isolated and probed by Western blot with antibody directed against the NF-kB p65 component.
Quantitative densitometric analysis demonstrated marked reduction of p65 nuclear translocation in HIV+ U1 macrophages compared to U937 macrophages (Fig. 1C ). To formally demonstrate whether MyD88 mediates TLR4 driven TNFα release, functional assays were carried out using targeted functional gene silencing of MyD88. A reduced MyD88 protein level was demonstrated in U937 macrophages after MyD88 silencing by 70-80% (Fig. 1D left panel) . TLR4-mediated TNFα release was robust in U937 with scrambled shRNA, whereas in MyD88 silenced cells, TLR4-mediated TNFα release was markedly diminished (Fig. 1D, right panel) , suggesting that TLR4-mediated TNFα release in human macrophages is predominantly MyD88-dependent. Taken together, these data demonstrate that human macrophage TNFα release is in part TLR4-dependent, MyD88-dependent and that reduced TLR4-mediated TNFα release in HIV+ macrophages is associated with impaired MyD88-dependent signaling (as determined by reduced MyD88-IRAK interaction, reduced IRAK phosphorylation, and reduced NFkB p65 nuclear translocation).
Preserved TLR4-mediated MyD88-independent pathway in HIV+ human macrophages. Next, to examine human macrophage TLR4-mediated MyD88-13-Tachado independent signaling pathway, studies focused on prototypic markers of the MyD88-independent signaling pathway, RANTES and IL-10 [26] [27] [28] [29] . Similar to the pattern of TNFα release in human macrophages described above, macrophage IL-10 release was significantly reduced in the presence of anti-TLR4 neutralizing antibody in both human U937 and HIV+ U1 macrophages in response to the TLR4 ligand lipid A suggesting that IL-10 release is mediated by TLR4 signaling pathway (Fig. 2A) . However, in contrast to TLR4-mediated TNFα release, release of IL-10 ( Fig 2B) and RANTES (Fig. 2C) were similar in magnitude in both U937 and HIV+ U1 human macrophages as measured by ELISA suggesting that TLR4-mediated MyD88-independent pathway is preserved in HIV+ macrophages. Furthermore, targeted gene silencing of MyD88 did not influence IL-10 or RANTES release in response to lipid A (Fig. 2D-E) , suggesting that in contrast to TLR4-mediated TNFα release (which is MyD88-dependent as above), TLR4-mediated IL-10 and RANTES release is predominantly MyD88-independent in human macrophages. The pattern of IL-10 release was confirmed in clinically relevant human alveolar macrophages, demonstrating similar levels of lipid A-mediated IL-10 release comparing alveolar macrophages from healthy individuals to alveolar macrophages from asymptomatic HIV+ persons (Fig. 2F) . The observed differences in TLR4-mediated TNFα and IL-10 release were not related to differences in macrophage expression of essential TLR4 modulator molecule MD2 30 ( Fig. 2G ) or surface expression of TLR4 co-receptor CD14 (Fig. 2H) , consistent with our prior studies demonstrating similar TLR4 surface expression comparing 937 and HIV+ U1 macrophages 7, 31 and comparing alveolar macrophages from healthy and HIV+ persons 8 . In contrast to impaired TLR4-mediated MyD88-dependent release of TNFα,
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collectively these data demonstrate that TLR4-mediated IL-10 and RANTES release in human macrophages is predominantly MyD88-independent, and suggest that HIV may specifically target the MyD88-dependent TLR4 signaling pathway, while preserving the MyD88-independent TLR4 signaling pathway.
TLR4-mediated IRF3 nuclear translocation and Stat-1 phosphorylation is preserved in HIV+ macrophages. To further examine the influence of HIV on TLR4-mediated MyD88-independent signaling pathway, studies focused on the activation of IRF3 and Stat1, important signaling molecules of the MyD88-independent pathway 26, 27 . Human U937 and HIV+ U1 macrophages were incubated with lipid A (10μg/ml) up to 240 minutes, and then nuclear and cytoplasmic extracts isolated and probed with specific anti-IRF3 antibody by Western blot. Experiments revealed limited constitutive IRF3 nuclear translocation in unstimulated U937 macrophages, followed by nuclear translocation within 15 minutes in response to Lipid A, peaking over 30-120 minutes followed by gradual decline by 240 minutes (Fig. 3A) . In comparison, HIV+ U1 macrophages demonstrated elevated constitutive IRF3 nuclear translocation in unstimulated macrophages, with further increased levels of IRF3 nuclear translocation in response to lipid A that continued to increase up to 240 minutes (Fig. 3B ).
Recognizing that TLR4-mediated MyD88-independent signaling through TRIF and IRF3 requires STAT-1 transcription factors 32 , we studied STAT-1 phosphorylation in untreated or lipid A treated U937 and HIV+ U1 cells. As shown in Fig 3C, time kinetics for Stat1 phosphorylation demonstrated low constitutive STAT-1 phosphorylation in unstimulated human U937 macrophages, but increased by 15 (Fig. 3C) . Taken together, in contrast to impaired TLR4-mediated MyD88-dependent signaling, these data suggest a preserved TLR4-mediated MyD88-independent signaling pathway in HIV+ macrophages. In the context of HIV infection, divergent regulation of MyD88-dependent and MyD88-independent TLR4 signaling pathways could underlie the differential gene expression and host cell responses in macrophages.
Targeted gene silencing of MyD88-independent signaling pathway molecules TRIF or IRF3 in human macrophages reduces TLR4-mediated RANTES release (but not TNFα release). TLR4-mediated MyD88-independent signal transduction is mediated through TRIF
12
. To determine whether TRIF regulates TLR4-mediated signaling in human macrophages, release of RANTES and TNFα was examined in the presence and absence of targeted functional gene silencing of TRIF using RNAi methodology. In human U937 and HIV+U1 macrophages, TRIF protein was constitutively expressed in the presence of non-silencing RNAi, but TRIF protein levels are markely reduced with TRIF-targeted gene silencing (Fig. 4A) . Furthermore, targeted gene silencing of TRIF was associated with reduction in lipid A-mediated RANTES release in both U937 macrophages (Fig. 4B ) and HIV+ U1 macrophages (Fig.   4C ). In contrast, lipid A-mediated TNFα release was not influenced by targeted gene silencing of TRIF, demonstrating specificity of MyD88-independent pathway (Fig. 4D ).
For
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To further investigate the MyD88-independent TLR4-mediated macrophage release of RANTES and TNFα, experiments were performed in the presence or absence of targeted gene silencing of IRF3, transcription factor downstream of TRIF signaling. In human U937 and HIV+ U1 macrophages, IRF3 protein was constitutively expressed in the presence of non-silencing RNAi, but IRF3 protein levels are markedly reduced following IRF3-targeted gene silencing (Fig. 4E) . Furthermore, targeted gene silencing of IRF3 was associated with reduction in lipid A-mediated RANTES release in both U937 macrophages (Fig. 4F ) and HIV+ U1 macrophages (Fig. 4G ). In contrast, lipid Amediated TNFα release was not influenced by targeted gene silencing of IRF3 (Fig.   4H ), suggesting that TLR4-mediated RANTES and IL-10 release by human macrophages is predominantly MyD88-independent. Taken together, these data suggest that TLR4-mediated release of RANTES and IL-10 in human macrophages is mediated through a MyD88-independent process involving TRIF and IRF3, whereas TLR4-mediated TNFα release in human macrophages is mediated through MyD88-dependent process and does not involve TRIF and IRF3 signaling molecules.
TLR4-mediated macrophage release of IL-10 and RANTES (but not TNFα) and IRF3 phosphorylation (but not ERK1/2 phosphorylation) dependent on TLR4
endocytosis. TLR4-mediated MyD88-independent signaling requires endocytosis, whereas TLR4-mediated MyD88-dependent signaling does not require endocytosis 11 .
We investigated the role of endocytosis in TLR4-mediated MyD88-dependent and MyD88-independent signaling pathways in human macrophages measuring macrophage IL-10, RANTES and TNFα release in response to lipid A in the presence
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and absence of an inhibitor of GTPase dynamin (Dynasore). Inhibition of endocytosis (with Dynasore) was shown to inhibit TLR4-mediated MyD88-independent dynaminmediated endocytosis 11 . As a measure of TLR4-mediated MyD88-independent signaling, incubation of human U937 or HIV+ U1 macrophages with lipid A in the presence of Dynasore markedly reduced macrophage IL-10 release (Fig. 5A ) and RANTES release (Fig. 5B) . In contrast, as a measure of TLR4-mediated MyD88-dependent signaling, lipid A-mediated TNFα release was not influenced by dynasore (Fig. 5C) . Furthermore, pretreatment of human U937 or HIV+ U1 macrophages with dynasore impaired lipid A -mediated IRF3 phosphorylation (MyD88-independent signaling molecule) but did not influence ERK1/2 phosphorylation (MyD88-dependent signaling molecule) (Fig. 5D ). These data demonstrate that in human macrophages, TLR4-mediated MyD88-independent signaling requires endocytosis (in contrast to TLR4-mediated MyD88-dependent signaling), and is not influenced by HIV infection.
Discussion:
This study demonstrates that HIV infection is associated with impaired human macrophage TLR4-mediated signaling, specifically targeting the MyD88-dependent The finding in the current study that TLR4-mediated impairment of TNFα release was significantly reduced in HIV+ macrophages is consistent with our prior observations 7, 8, 20 and observations by other investigators 31, 33 . TLR4 is unique among the TLR family, supporting both MyD88-dependent and MyD88-independent signaling pathways 11 , whereas TLR3 exhibits MyD88-independent signaling and all other TLR exhibit MyD88-dependent signaling 34 . Activation of MyD88-dependent signaling pathway promotes pro-inflammatory cytokine release such as TNFα and IL-12 35 , while activation phosphorylation suggest that the MyD88-independent signaling pathway represents that principal mechanism for IL-10 and RANTES release in HIV+ macrophages. Also, the finding in the current study that MyD88-independent TLR4-mediated signaling requires endocytosis whereas MyD88-dependent TLR4-mediated signaling does not require endocytosis is consistent with data from other investigators 11 and extends the concept of distinct molecular mechanisms for TLR4-mediated signaling to human macrophages.
The current study provides an additional mechanism for the observed reduction in TLR4-mediated TNFα release in HIV+ macrophages 7, 8, 20 . Our prior work demonstrated that the observed reduction in macrophage TLR4-mediated TNFα release in HIV+ macrophages may in part be attributed to activation of macrophage cellular phosphatase MKP-1 7 , and may in part be attributed to constitutive activation of PI3K pathway 8 . The current study extends the mechanisms to include impaired TLR4-mediated MyD88-dependent signaling pathway, suggesting that chronic HIV infection may influence macrophage innate immune signaling pathways at several molecular levels. Importantly, our prior observations that pharmacological agents can partially restore macrophage TLR4-mediated immune functions in alveolar macrophages from HIV+ persons 7 suggest the potential for immunomodulation of macrophage innate immune function to restore host cell response bacterial challenge.
Recognizing that HIV infection of macrophages is generally non-productive 36 , the preserved or elevated levels of IRF3 and pSTAT1 in HIV+ macrophages may in part
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represent antiviral mechanism to limit or control HIV replication in macrophages. IRF3 signaling in general is MyD88-independent and may involve TRAF3 self ubiquitination 37 . A consequence of preserved or elevated IRF3 signaling to limit viral replication may be impaired MyD88-dependent signaling, although was not specifically established in the current study and represents an area of active investigation.
The mechanism for the select impairment of MyD88-dependent TLR4 signaling (while preserving MyD88-independent signaling) was not established in the current study. In the current study, the observed differences in TLR4-mediated signaling comparing healthy and HIV+ human macrophages was not related to differences in macrophage expression of the TLR4 signaling complex, as MD2 levels and surface expression of CD14 were similar. Our prior publications demonstrated similar levels of macrophage TLR4 surface expression and TLR4 mRNA 7, 8 , confirmed by other independent investigators 31 . Taken together, these data suggest that the TLR4-MD2-CD14 signaling complex is intact in both alveolar macrophages from healthy individuals and alveolar macrophages from asymptomatic HIV+ persons, and suggests that impairment of signaling in HIV+ macrophages represents events downstream of the TLR4 receptor complex. Our prior investigations demonstrated that HIV nef protein is sufficient to induce macrophage MKP-1 7 , activate PI3K 8 , and impair TLR4-mediated TNFα release 8 suggests that HIV nef protein may selectively influence MyD88-dependent TLR4-mediated signaling, although this mechanism was not specifically investigated in the current study. Our prior observation that HIV nef was sufficient to impair TLR4-mediated TNFα release while simultaneously promoting IL-10 release 8 is 21-Tachado consistent with findings in the current study, suggesting targeted effects of MyD88-dependent TLR4-mediated signaling.
Other limitations of the current study include whether the findings are specific to TLR4 or whether MyD88-dependent signaling was affected in other macrophage TLRs was not investigated. Also, whether these findings apply in general to the other family members of the TIR-containing domains 38 was not established. Finally, the in vitro observations may not accurately reflect in vivo function, but the use of clinically relevant human AM may allow for more direct translation of observed results to human disease.
This is the first study to report that MyD88-dependent signaling pathway is specifically targeted by HIV that resulted in diminished TLR4-mediated TNFα release in response to lipid A. Importantly, the TLR4-mediated MyD88-independent pathway is preserved in HIV+ human macrophages leading to robust IL-10 and RANTES release in response to lipid A. Furthermore, it has been recently shown that HIV induces downregulation of IRAK-4 and inhibits TNFα in response to TLR4 activation and supports the present study 24 .Taken together, these observations support the concept that HIV infection is associated with targeted and specific impairment of macrophage innate immune function rather than a global impairment of macrophage function.
In conclusion, this study demonstrates that the impaired TLR4-mediated macrophage response demonstrated in HIV-infected human macrophages is targeted to the MyD88-dependent signaling pathway, whereas the TLR4-mediated MyD88
For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From 22-Tachado independent signaling pathway is preserved. Recognizing that the MyD88-dependent signaling pathway is critical to the acute inflammatory response that promotes clearance of various pathogens [39] [40] [41] [42] , impaired MyD88-dependent TLR4-mediated in alveolar macrophages from HIV+ persons may contribute to bacterial pneumonia pathogenesis.
In general, this study supports the concept that chronic HIV infection is associated with altered macrophage innate immune function. Moreover, the influence of chronic HIV infection on macrophage innate immune function is targeted and specific, with evidence of impaired innate immune pathways (ex. MyD88-dependent TLR4 signaling) while other innate immune pathways remain preserved (ex. MyD88-independent signaling). and U1 macrophages were pre-treated with a highly specific dynamin GTPase inhibitor (dynasore 50μM) for 1h and then incubated in the presence or absence of lipid A (10 µg/ml) for 15 mins, and cell lysates probed with specific antibodies to phosphorylated ERK1/2 and phosphorylated IRF3 antibody. Protein loading controls utilized antibody to 
